Therapeutics

Top Story

Pfizer announces leadership team for combined company after proposed Allergan merger

February 12, 2016

Pfizer announced in a press release its executive leadership team for the combined Pfizer and Allergan business following the close of the proposed merger of the companies.

Through the closing of the transaction, Pfizer’s Global Innovative Pharma (GIP) business and its Vaccines Oncology and Consumer (VOC) business will operate separately under Albert Bourla, currently group president of VOC, according to the release. When the transaction is complete, the VOC and GIP businesses will combine, with Bourla becoming group president, Global Innovative Pharma, leading the combined businesses, according to the release.

Breaking News

Doctors urge Congress to preserve the 340B Drug Pricing Program

February 11, 2016
Thousands of physicians from American safety-net hospitals signed a letter sent to Congress highlighting the importance of the 340B Drug Pricing Program.The letter asks…

AGA survey shows chronic pain patients at risk of overdosing on OTC pain medications

January 26, 2016
Many chronic pain patients ignore labels on over-the-counter pain relievers and increase their risk for overdose and gastrointestinal side effects, according to results…
Perspectives on Glaucoma

Ibopamine provocative test may be useful in diagnosing early stages of glaucoma

January 4, 2016
The ibopamine provocative test may detect an increased risk of glaucoma at an early stage of the disease, according to a study.The prospective study compared 44 subjects…

Pfizer announces leadership team for combined company after proposed Allergan merger

February 12, 2016
Pfizer announced in a press release its executive leadership team for the combined Pfizer and Allergan business following the close of the proposed…
Breaking News

Doctors urge Congress to preserve the 340B Drug Pricing Program

February 11, 2016
Thousands of physicians from American safety-net hospitals signed a letter sent to Congress highlighting the importance of the 340B Drug Pricing…

AGA survey shows chronic pain patients at risk of overdosing on OTC pain medications

January 26, 2016
Many chronic pain patients ignore labels on over-the-counter pain relievers and increase their risk for overdose and gastrointestinal side effects…
Perspectives on Glaucoma

Ibopamine provocative test may be useful in diagnosing early stages of glaucoma

January 4, 2016
The ibopamine provocative test may detect an increased risk of glaucoma at an early stage of the disease, according to a study.The prospective study…
Perspectives on Glaucoma

Educate glaucoma patients on efficacy, adverse effects of marijuana

December 28, 2015
Researchers highlight the need for more education on the use of marijuana in treating glaucoma in a study from JAMA Ophthalmology. Belyea and…
In the Journals

Drug release affected by contact lens material, system used

December 9, 2015
Researchers observed a higher fluconazole release in the vial compared with an eye model, as well as differences in drug release among contact lens…

IOP-lowering solution launches under Westminster Pharmaceuticals

December 3, 2015
Trxade Group Inc. and its subsidiary, Westminster Pharmaceuticals LLC, have launched brimonidine solution 0.2% as part of an exclusive agreement with…

NIH: Lucentis effectively treats proliferative diabetic retinopathy

December 2, 2015
Ranibizumab is a viable treatment option for people with proliferative diabetic retinopathy, according to results from a clinical trial funded by the…
Video

VIDEO: Consider systemic factors when prescribing orals

December 1, 2015
Bisant Labib, OD, FAAO, discusses how patients systemic diseases can influence the oral drugs optometrists prescribe.In her continuing education talk…
Business News

Phase 3 clinical trial enrollment begins for ocular allergy drug

November 30, 2015
Enrollment is underway for a second phase 3 clinical trial of Dextenza sustained release dexamethasone for treatment of allergic conjunctivitis…
More Headlines »
morganatic-roan morganatic-roan